Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ ANLEIHEN-Woche #KW34 – 2025: Energiekontor, JDC, The Platform Group, Aream, LEEF, Dt. Rohstoff,... (Anleihen-Finder) +++ PLATFORM GROUP Aktie +4,84%

VITROLIFE Aktie

 >VITROLIFE Aktienkurs 
12.39 EUR    +1.8%    (Tradegate)
Ask: 12.42 EUR / 250 Stück
Bid: 12.31 EUR / 255 Stück
Tagesumsatz: 509 Stück
Realtime Kurs von 8 bis 22 Uhr!
VITROLIFE Aktie über LYNX handeln
>VITROLIFE Performance
1 Woche: +2,1%
1 Monat: -2,0%
3 Monate: -10,5%
6 Monate: -34,4%
1 Jahr: -35,5%
laufendes Jahr: -34,1%
>VITROLIFE Aktie
Name:  VITROLIFE AB SK 0,2
Land:  Schweden
Sektor:  Gesundheit
ISIN/ Wkn:  SE0011205202 / A2JLT3
Symbol/ Ticker:  VTFN (Frankfurt)
Kürzel:  FRA:VTFN, ETR:VTFN, VTFN:GR
Index:  -
Webseite:  https://www.vitrolife.com..
Profil:  Vitrolife AB is a prominent biotechnology company ..
>Volltext..
Marktkapitalisierung:  1660.74 Mio. EUR
Unternehmenswert:  1755.66 Mio. EUR
Umsatz:  317.76 Mio. EUR
EBITDA:  103.44 Mio. EUR
Nettogewinn:  40.94 Mio. EUR
Gewinn je Aktie:  0.3 EUR
Schulden:  178.95 Mio. EUR
Liquide Mittel:  82.69 Mio. EUR
Operativer Cashflow:  62.22 Mio. EUR
Bargeldquote:  1.44
Umsatzwachstum:  2.01%
Gewinnwachstum:  -
Dividende je Aktie:  0.1 EUR
Dividendenrendite:  0.81%
Dividendenschätzung:  0.79%
Div. Historie:  30.04.25 - 0.09944001€
26.04.24 - 0.09061€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  VITROLIFE
Letzte Datenerhebung:  23.08.25
>VITROLIFE Kennzahlen
Aktien/ Unternehmen:
Aktien: 135.42 Mio. St.
Frei handelbar: 53.53%
Leerverk. Aktien: -
Rückkaufquote: -
Mitarbeiter: 1120
Umsatz/Mitarb.: 0.25 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 41.78%
Bewertung:
KGV: 41.33
KGV lG: 33.79
KUV: 5.25
KBV: 1.41
PEG-Ratio: -
EV/EBITDA: 16.97
Rentabilität:
Bruttomarge: 51.51%
Gewinnmarge: 12.88%
Operative Marge: 20.12%
Managementeffizenz:
Gesamtkaprendite: 2.71%
Eigenkaprendite: 3.46%
>VITROLIFE Peer Group

Es sind 150 Aktien bekannt.
 
17.07.25 - 14:33
Vitrolife AB (publ) reports Q2 results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
03.07.25 - 14:24
Invitation to Vitrolife Group′s presentation of the Q2 2025 interim report (PR Newswire)
 
GOTHENBURG, Sweden, July 3, 2025 /PRNewswire/ -- Vitrolife AB (publ) will publish its Q2 2025 interim report on Thursday, 17 July 2025 at 08:00 am CEST. A conference call for investors, analysts and financial media will be held at 10:00 am CEST the same day. The presentation will be held......
01.07.25 - 11:18
Vitrolife Group completes refinancing facility backed by leading Nordic Banks (PR Newswire)
 
GOTHENBURG, Sweden, July 1, 2025 /PRNewswire/ -- Vitrolife AB (publ) has today renewed and signed a loan agreement of EUR 300 million comprising of term loan and revolving credit facility. The term loan will be used to refinance existing debt and the revolving credit facility will be......
28.05.25 - 09:24
Gardening Market Worth USD 150 Billion by 2030 - Industry Size, Trends, Analysis, Growth-rate, and Top Manufacturers (Vitrolife, Scotts Miracle-Gro Company, The Home Depot & Others) (PR Newswire)
 
NEW DELHI, May 28, 2025 /PRNewswire/ -- The Global Gardening Market size was valued at approximately USD 120 billion in 2024, with projections estimating it will expand to USD 150 billion by 2030. According to a recent gardening market analysis by MarkNtel Advisors, this growth reflects a......
09.05.25 - 22:48
AutoIVF Announces Syndicated Investment Round, Led by Vitrolife AB (publ) (Business Wire)
 
NATICK, Mass.--(BUSINESS WIRE)--AutoIVF Inc., a pioneering fertility care company, has closed an equity investment round, led by Vitrolife Group, with participation from new investors including Alpha Edison and IVF industry stalwarts.  AutoIVF's flagship product, OvaReady, is a groundbreaking automated system that simplifies and enhances egg retrieval and preparation in the current IVF process and supports decentralizing the egg retrieval process outside traditional IVF laboratory settings. According to the World Health Organization (WHO), one in six people globally will experience infertility at some point in their lives. This underscores the urgent need for accessible, high-quality fertility care worldwide. Led by CEO Ravi Kapur Ph.D., FAIMBE, AutoIVF's founding and leadership team brings more than 200 years of combined experience in IVF, microfluidics, and reproductive health, driving its mission to democratize fertility care, expand global access, and reimagine the future of assisted reproductive t...
08.05.25 - 16:09
Vitrolife AB (publ) becomes lead investor in AutoIVF (PR Newswire)
 
GOTHENBURG, Sweden, May 8, 2025 /PRNewswire/ -- The Vitrolife Group today announces it has become a leading investor in AutoIVF. This strategic investment aligns with our corporate strategy of improving affordability and access to IVF to patients around the world. AutoIVF, is an......
30.04.25 - 09:27
Report from Annual General Meeting of Vitrolife AB (publ) (PR Newswire)
 
GOTHENBURG, Sweden, April 30, 2025 /PRNewswire/ -- At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided: Resolution in accordance with the Board's proposed dividend of SEK 1.10 per share for the financial year 2024. 2 May, 2025 was adopted......
30.04.25 - 09:12
Report from Annual General Meeting of Vitrolife AB (publ) (Cision)
 
At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided: · Resolution in accordance with the Board's proposed dividend of SEK 1.10 per share for the financial year 2024. 2 May, 2025 was adopted as the record day. · Re-election of Board members Henrik Blomquist, Lars Holmqvist, Pia Marions, Jón Sigurdsson and Karen Lykke Sørensen, in accordance with the election committee's proposal. Jón Sigurdsson was elected Chairman of the Board. · Remuneration to the Board members is proposed to be in total SEK 3 670 000 (3 300 000) of which...
29.04.25 - 17:15
Report from Annual General Meeting of Vitrolife AB (publ) (PR Newswire)
 
GOTHENBURG, Sweden, April 29, 2025 /PRNewswire/ -- At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided: Resolution in accordance with the Board's proposed dividend of SEK 1.10 per share for the financial year 2024. 2 May, 2025 was adopted......
29.04.25 - 17:00
Report from Annual General Meeting of Vitrolife AB (publ) (Cision)
 
At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided: · Resolution in accordance with the Board's proposed dividend of SEK 1.10 per share for the financial year 2024. 2 May, 2025 was adopted as the record day. · Re-election of Board members Henrik Blomquist, Lars Holmqvist, Pia Marions, Jón Sigurdsson and Karen Lykke Sørensen, in accordance with the election committee's proposal. Jón Sigurdsson was elected Chairman of the Board. · Remuneration to the Board members is proposed to be in total SEK 3 670 000 (3 300 000) of which SEK 1...
28.04.25 - 23:48
XFRA: DIVIDEND/INTEREST INFORMATION - 30.04.2025 - SE0011205202 (XETRA)
 
Das Instrument VTFN SE0011205202 VITROLIFE AB SK 0,2 EQUITY wird cum Dividende/Zinsen gehandelt am 29.04.2025 und ex Dividende/Zinsen am 30.04.2025 The instrument VTFN SE0011205202 VITROLIFE AB SK 0,2 EQUITY has its pre-dividend/interest day on 29.04.2025 and its ex-dividend/interest day on 30.04.2025...
24.04.25 - 08:21
Vitrolife AB (publ) Interim report Q1, 2025: Strong performance in EMEA (PR Newswire)
 
GOTHENBURG, Sweden, April 24, 2025 /PRNewswire/ -- First quarter Sales of SEK 842 (841) million, an increase of 1% in local currencies and 0% in SEK. The growth in local currencies excluding discontinued business was 3%. Sales per region, in local currencies was +8% in EMEA, +14%......
10.04.25 - 13:15
Vitrolife names Pär Ihrskog as finance chief (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
10.04.25 - 12:33
The Vitrolife Group appoints Pär Ihrskog as the new Chief Financial Officer (PR Newswire)
 
GOTHENBURG, Sweden, April 10, 2025 /PRNewswire/ -- Pär Ihrskog has been appointed CFO of the Vitrolife Group effective 10 October 2025. Pär currently serves as CFO at Bufab Group and brings a wealth of experience to the company, having also served as Group CFO/CIO at Embellence Group. He......
10.04.25 - 10:33
Conference call interim report (PR Newswire)
 
GOTHENBURG, Sweden, April 10, 2025 /PRNewswire/ -- Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q1 2025. The presentation will be held in English. Time: Thursday 24 April, 2025 at 10.00 a.m. CET. To attend the conference call,......
31.03.25 - 14:45
The Vitrolife Group introduces changes to the executive management team and strengthens focus on innovation (PR Newswire)
 
GOTHENBURG, Sweden, March 31, 2025 /PRNewswire/ -- To further drive the execution of the Vitrolife Group corporate strategy, the company is evolving the executive management team and introducing a SVP Innovation role to accelerate the pace and output of innovation. Rickard Ericsson,......
27.03.25 - 09:39
Vitrolife Group Annual and Sustainability Report 2024 (PR Newswire)
 
GOTHENBURG, Sweden, March 27, 2025 /PRNewswire/ -- Vitrolife Group has today published its Annual and Sustainability Report for 2024. The Annual and Sustainability Report is now available digitally in English and Swedish at www.vitrolifegroup.com. The Annual Report in accordance with......
27.03.25 - 09:06
Vitrolife Group Annual and Sustainability Report 2024 (Cision)
 
Vitrolife Group has today published its Annual and Sustainability Report for 2024. The Annual and Sustainability Report is now available digitally in English and Swedish at www.vitrolifegroup.com. The Annual Report in accordance with European Single Electronic Format (ESEF) is available in Swedish. Vitrolife Group has chosen not to print or distribute a hard copy of the Annual Report. Those who are unable to access the Annual Report digitally can request a print-out of the Annual Report by contacting Vitrolife Group at investors@vitrolife.com or call +46 (0) 31 721 80 00. Gothenburg,...
25.03.25 - 18:54
Notice to attend the Annual General Meeting of Vitrolife AB (publ) (PR Newswire)
 
GOTHENBURG, Sweden, March 25, 2025 /PRNewswire/ -- The shareholders of Vitrolife AB (publ) are hereby invited to attend the Annual General Meeting of shareholders on 29 April 2025 at 4.00 pm at the Elite Park Avenue Hotel, Kungsportsavenyn 36-38 in Gothenburg, Sweden. The entrance opens......
05.03.25 - 19:24
In light of the recent PGT-A class action lawsuit filings in a court in Florida, Vitrolife Group issues the following statement (PR Newswire)
 
GOTHENBURG, Sweden, March 5, 2025 /PRNewswire/ -- Vitrolife Group is aware that a PGT-A class action lawsuit has been filed against Vitrolife AB (publ), Vitrolife Inc and Igenomix USA, Inc in the court of the Southern District of Florida, although no formal complaint has been served yet.......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ein Politiker verschweigt oft auch das, was er nicht weiß. - Dr. Fritz P. Rinnhofer
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!